Skip to main content

Advertisement

SpringerLink
Log in

Autoantibodies in insulin-dependent diabetes mellitus

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. 13th Forum in Immunology. The Origin and nature of autoantibodies. Ann. Inst. Pasteur. Immunol 137D: 139, 1986.

  2. Eisenbarth G.S. Type 1 diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314: 1360, 1986.

    PubMed  CAS  Google Scholar 

  3. Bottazzo G.F. Death of a beta cell: homicide or suicide? Diab. Med. 3: 119, 1986.

    CAS  Google Scholar 

  4. Bosi E., Todd I., Pujol-Borrell R., Bottazzo G.F. Mechanisms of autoimmunity: relevance to the pathogenesis of Type 1 (insulin-dependent) diabetes mellitus. Diabetes Metab. Rev. 3: 893, 1987.

    PubMed  CAS  Google Scholar 

  5. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619, 1965.

    PubMed  CAS  Google Scholar 

  6. Bastenie P.A., Gepts W. (Eds). Immunology and autoimmunity in diabetes mellitus. Excerpta Medica, Amsterdam 1974.

    Google Scholar 

  7. Bottazzo G.F., Florin-Christensen A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii: 1279, 1974.

    Google Scholar 

  8. Lendrum R., Walker I.G., Gamble D.R. Islet cell antibodies in juvenile diabetes mellitus of recent onset. Lancet i: 880, 1975.

    Google Scholar 

  9. Landin-Olsson M., Karlsson A., Dahlquist G., Blom L., Lernmark A., Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing Type I (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387, 1989.

    PubMed  CAS  Google Scholar 

  10. Bottazzo G.F., Gleichmann H. Immunology and Diabetes Workshops: report of the First International Workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 29: 125, 1986.

    Google Scholar 

  11. Gleichmann H., Bottazzo G.F. Progress towards standardization of cytoplasmic islet-cell antibody assays. Diabetes 36: 578, 1987.

    PubMed  CAS  Google Scholar 

  12. Bonifacio E., Dawkins R.L., Lernmark A. Immunology and Diabetes Workshops: report of the Second International Workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 30: 273, 1987.

    Google Scholar 

  13. Bonifacio E., Lernmark A., Dawkins R. Serum exchange and use of dilutions have improved precision and measurement of islet cell antibodies. J. Immunol. Methods 106: 83, 1988.

    PubMed  CAS  Google Scholar 

  14. Boitard C., Bonifacio E., Bottazzo G.F., Glechmann H., Molenaar J. Immunology and Diabetes Workshops: report of the Third International (Stage III) Workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 31: 451, 1988.

    PubMed  CAS  Google Scholar 

  15. Bonifacio E., Boitard C., Gleichmann H., Shattock M.A., Molenaar J.L., Bottazzo G.F. Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33: 731, 1990.

    PubMed  CAS  Google Scholar 

  16. Lernmark A., Molenaar J.L., Van Beers W.A.M., Yamaguchi Y., Nagataki S., Ludvigsson J., Maclaren N.K. The Fourth International serum exchange Workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 34: 534, 1991.

    PubMed  CAS  Google Scholar 

  17. Greenbaum C.J., Palmer J.P., Nagataki S., Yamaguchi Y., Molenaar J.L., Van Beers W.A.M., Maclaren N.K., Lernmark A., and Participating Laboratories Improved specificity of ICA assays in the Fourth International Immunology of Diabetes serum exchange Workshop. Diabetes 41: 1570, 1992

    PubMed  CAS  Google Scholar 

  18. Schatz D.A., Barrett D.J., Maclaren N.K., Riley W.J. Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity 1: 45, 1988.

    PubMed  CAS  Google Scholar 

  19. Dozio N., Belloni C., Girardi A.M., Genovese S., Sodoyez J.C., Bottazzo G.F., Pozza G., Bosi E. Heterogeneous IgG subclass distribution of islet cell antibodies. J. Autoimmun. 7: 45, 1994.

    PubMed  CAS  Google Scholar 

  20. Bottazzo G.F., Dean B.M., Gorsuch A.N., Cudworth A.G., Doniach D. Complement-fixing islet-cell antibodies in Type I diabetes: possible monitors of active beta-cell damage. Lancet i: 668, 1980.

    Google Scholar 

  21. Genovese S., Bonifacio E., McNally J.M., Dean B.M., Wagner R., Bosi E., Gale E.A.M., Bottazzo G.F. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385, 1992.

    PubMed  CAS  Google Scholar 

  22. Gianani R., Pugliese A., Bonner-Weir S., Shiffrin A.J., Soeldner J.S., Erlich H., Awdeh Z., Alper C.A., Jackson R.A., Eisenbarth G.S. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41: 347, 1992.

    PubMed  CAS  Google Scholar 

  23. Gorsuch A.N., Spencer K.M., Lister J., McNally J.M., Dean B.M., Bottazzo G.F., Cudworth A.G. Evidence for a long pre-diabetic period in type I (insulin-dependent) diabetes mellitus. Lancet ii: 1363, 1981.

    Google Scholar 

  24. Tarn A.C., Thomas J.M., Dean B.M., Ingram D., Schwarz G., Bottazzo G.F., Gale E.A.M. Predicting insulin dependent diabetes. Lancet i: 845, 1988.

    Google Scholar 

  25. Johnstone C., Millward B.A., Hoskins P., Leslie R.D.G., Bottazzo G.F., Pyke D.A. Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins. Diabetologia 32: 382, 1989.

    Google Scholar 

  26. Bosi E., Becker F., Bonifacio E., Wagner R., Collins P., Gale E.A.M., Bottazzo G.F. Progression to Type I (insulin-dependent) diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 40: 977, 1991.

    PubMed  CAS  Google Scholar 

  27. Bonifacio E., Bingley P.G., Shattock M., Dean B.M., Dunger D., Gale E.A.M., Bottazzo G.F. Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147, 1990.

    PubMed  CAS  Google Scholar 

  28. Bingley P.J., Bonifacio E., Shattock M., Gillmor H.A., Sawtell P.A., Dunger D.B., Scott R.D.M., Bottazzo G.R. Gale E.A.M. Can islet cell antibodies predict insulin dependent diabetes in the general population? Diabetes Care 16: 45, 1993.

    CAS  Google Scholar 

  29. Bingley P.J., Bonifacio E., Gale E.A.M. Can we really predict IDDM? Diabetes 42: 213, 1993.

    PubMed  CAS  Google Scholar 

  30. Bosi E., Andreotti A.C., Girardi A.M., Bottazzo G.F., Pozza G. The long-term persistence of islet cell antibodies in type 1 diabetic patients is unrelated to residual ß-cell function. Diab. Nutr. Metab. 4: 319, 1991.

    Google Scholar 

  31. Lendrum R., Walker I.G., Cudworth A.G., Theophanides C., Pyke D.A., Bloom A., Gamble D.R. Islet cell antibodies in diabetes mellitus. Lancet ii: 1273, 1976.

    Google Scholar 

  32. Atkinson M.A., Kaufman D.L., Newman D., Tobin A.J., Maclaren N.K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91: 350, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  33. Nayak R.S., Omar M.A.K., Rabizadeh A., Srikanta S., Eisenbarth G.S. “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 34: 617, 1984.

    Google Scholar 

  34. Colman P.G., Nayak R.C., Campbell I.L., Eisenbarth G.S. Binding of ‘cytoplasmic’ islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37: 645, 1988.

    PubMed  CAS  Google Scholar 

  35. Baekkeskov S., Nielson J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantiboides in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell protein. Nature 298: 167, 1982.

    PubMed  CAS  Google Scholar 

  36. Baekkeskov S., Dyrberg T., Lernmark A. Autoantibodies to the 64 kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 224: 1348, 1984.

    PubMed  CAS  Google Scholar 

  37. Atkinson M.A., Maclaren N.K. Autoantibodies in NOD mice immunoprecipitate an 64,000 Mr islet cell antigen. Diabetes 37: 1587, 1988.

    PubMed  CAS  Google Scholar 

  38. Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark A., Baekkeskov S. Antibodies to a Mr 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 31: 597, 1988.

    PubMed  CAS  Google Scholar 

  39. Baekkeskov S., Landin M., Kristensen J.K., Srikanta S., Bruining G.J., Mandrup-Poulsen T., De Beaufortt C., Soeldner J.S., Eisenbarth G., Lindgren F., Sundqvist G., Lernmark A. Antibodies to a 64000 Mr human islet cell protein precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 79: 926, 1987.

    PubMed Central  PubMed  CAS  Google Scholar 

  40. Atkinson M.A., Maclaren N.K., Scharp D.W., Lacy P.E., Riley W.J. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 35: 1357, 1990.

    Google Scholar 

  41. Baekkeskov S., Warnock G., Christie M., Rajotte R.V., Mose Larsen P., Fey S. Revelation of specificity of 64K autoantibodies in IDDM serums by high resolution two-dimensional gel electrophoresis: unambiguous identification of 64K target antigen. Diabetes 38: 1133, 1989.

    PubMed  CAS  Google Scholar 

  42. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylases. Nature 347: 151, 1990.

    PubMed  CAS  Google Scholar 

  43. Legay F., Pelhate S., Tappaz M.L. Phylogenesis of brain glutamic acid decarboxylase from vertebrate: immunochemical studies. J. Neurochem. 46: 1478, 1986.

    PubMed  CAS  Google Scholar 

  44. Vincent S.R., Hokfelt T., Wu J.Y., Elde R.P., Morgan L.M., Kimmel J.R. Immunohistochemical studies of the GABA system in the pancreas. Neuroendocrinology 36: 197, 1983.

    PubMed  CAS  Google Scholar 

  45. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., De Camilli P. GABA and pancreatic b cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J. 10: 1275, 1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  46. Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in Stiff-man syndrome. N. Engl. J. Med. 322: 1555, 1990.

    PubMed  CAS  Google Scholar 

  47. Marshall M.O., Moyer P.E., Petersen J.S., Hejnaes K.R., Genovese S., Dyrberg T., Bottazzo G.F. Contribution of glutamate decarboxylase antibodies to the reactivity of cytoplasmic islet cell antibodies. J. Autoimmun. (in press).

  48. Martino G.V., Tappaz M., Braghi S., Dozio N., Canal N., Pozza G., Bottazzo G.F., Grimaldi L.M.E., Bosi E. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to in insulin-dependent diabetes mellitus and islet cell antibodies. J. Autoimmun. 4: 915, 1991.

    PubMed  CAS  Google Scholar 

  49. Thivolet C.H., Tappaz M., Durand A., Petersen J., Stefanutti A., Chatelain P., Vialettes B., Scherbaum W., Orgiazzi J. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35: 570, 1992.

    PubMed  CAS  Google Scholar 

  50. Christie M.R., Brown T.J., Cassidy D. Binding of antibodies in sera from Type 1 (insulin-dependent) diabetes patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35: 380, 1992.

    CAS  Google Scholar 

  51. De Aizpurua H.J., Harrison L.C., Cram D.S. An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41: 1182, 1992.

    Google Scholar 

  52. Schmidli R.S., Colman P.G., Bonifacio E., Bottazzo G.F., Harrison L.C. and participating laboratories High level of concordance between assays for glutamic acid decarboxylase antibodies (GADAb): the first International GADAb Workshop. Diabetes (in press).

  53. Hagopian W.A., Karlsen A.E., Gottsater, Landin-Olsson M., Grubin C.E., Sundqvist G., Petersen J.S., Boel E., Dyrberg T., Lernmark A. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 91: 368, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  54. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B.K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: 459, 1994.

    PubMed  CAS  Google Scholar 

  55. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A. A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344, 1994.

    PubMed  CAS  Google Scholar 

  56. Hagopian W.A., Michelsen B., Karlsen A.E., Larsen F., Moody A., Grubin C.E., Rowe R., Petersen J., Mcevoy R., Lernmark A. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42: 631, 1993.

    PubMed  CAS  Google Scholar 

  57. Velloso L.A., Kampe O., Hallberg A., Christmanson L., Betsoltz C., Karlsson F.A. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eucaryotic expression. J. Clin. Invest. 91: 2084, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  58. Petersen J.B., Russel S., Marshall M.O., Kofod H., Bushard K., Cambon N., Karlsen A.E., Boel E., Hagopian W.A., Hejnaes K.R., Dyrberg T., Lernmark A., Madsen O., Michelsen B.K. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42: 484, 1993.

    PubMed  CAS  Google Scholar 

  59. Richter W., Shi Y., Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 90: 2832, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  60. Solimena M., De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 14: 452, 1991.

    PubMed  CAS  Google Scholar 

  61. Butler M.H., Solimena M., Dirkx R., Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in Stiff-Man syndrome. J. Exp. Med. 178: 2097, 1993.

    PubMed  CAS  Google Scholar 

  62. Bjork E., Velloso L.A., Kampe O., Karlsson A. GAD autoantibodies in IDDM, Stiff-Man syndrome and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43: 161, 1994.

    PubMed  CAS  Google Scholar 

  63. Harrison L.C., Honeyman M.C., DeAizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. An inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in humans at risk for insulin dependent diabetes. Lancet 381: 1365, 1993.

    Google Scholar 

  64. Kaufman D., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69, 1993.

    PubMed  CAS  Google Scholar 

  65. Tisch R., Yang X.D., Singer S., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72, 1993.

    PubMed  CAS  Google Scholar 

  66. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337, 1983.

    PubMed  CAS  Google Scholar 

  67. Wilkin T.J., Palmer J., Bonifacio E., Diaz J.L., Kruse V. First International Workshop on the standardisation of insulin autoantibodies. Diabetologia 30: 676, 1987.

    Google Scholar 

  68. Wilkin T., Palmer J., Kurtz A., Bonifacio E., Diaz J.L. The Second International Workshop on the standardisation of insulin autoantibody (IAA) measurement. Diabetologia 31: 449, 1988.

    PubMed  CAS  Google Scholar 

  69. Wilkin T.J., Schoenfeld S.L., Diaz J.L., Kruse V., Bonifacio E., Palmer J.P. and participating laboratories. Systematic variation accounts for much of the differences in insulin autoantibody measurements. Diabetes 38: 172, 1989.

    CAS  Google Scholar 

  70. Palmer J.P., Wilkin T.J., Kurtz A.B., Bonifacio E. The Third International Workshop on the standardization of insulin autoantibody measurement. Diabetologia 33: 60, 1990.

    PubMed  CAS  Google Scholar 

  71. Kuglin B., Kolb H., Greenbaum C., Maclaren N.K., Lernmark A., Palmer J.P. The Fourth International Workshop on standardisation of insulin autoantibody measurement. Diabetologia 33: 638, 1990.

    PubMed  CAS  Google Scholar 

  72. Greenbaum C.J., Palmer J.P., Kuglin B., Kolb H. and Participating Laboratories. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the standardization of insulin autoantibody measurement. J. Clin. Endocrinol. Metab. 74: 1040, 1992.

    CAS  Google Scholar 

  73. Greenbaum C.J., Wilkin T.J., Palmer J.P. Fifth International serum exchange Workshop for insulin autoantibody (IAA) standardization. Diabetologia 35: 798, 1992.

    PubMed  CAS  Google Scholar 

  74. Sodoyez-Goffaux F., Koch M., Dozio N., Brandenburg D., Sodoyez J.C. Advantages and pitfalls of radioimmune, enzyme linked immunosorbent assays of insulin antibodies. Diabetologia 31: 694, 1988.

    PubMed  CAS  Google Scholar 

  75. Vardi P., Dib S.A., Tuttleman M., Connelly J.E., Grindsberg M., Rabizadeh A., Riley W.J., Maclaren N.K., Eisenbarth G.S., Soeldner J.S. Competitive insulin autoantibody assay: prospective evaluation of subjects at risk for development of type I diabetes mellitus. Diabetes 36: 1286, 1987.

    PubMed  CAS  Google Scholar 

  76. Vardi P., Ziegler A.G., Matthews J.H., Dib S., Keller R.J., Ricker A.T., Wolfsdorf J.I., Herskovitz R.D., Rabizadeh A., Eisenbarth G.S., Soeldner J.S. Concentration of insulin autoantibodies at onset of type I diabetes — inverse log-linear correlation with age. Diabetes Care 11: 736, 1988.

    PubMed  CAS  Google Scholar 

  77. Gotfredsen C.F., Bushard K., Frandsen E.K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetesprone animals. Diabetologia 28: 933, 1988.

    Google Scholar 

  78. Atkinson M.A., Maclaren N.K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933, 1990.

    PubMed  CAS  Google Scholar 

  79. Zhang Z.J., Davidson L., Eisenbarth G., Winer H.L. Suppression of diabetes in non obese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252, 1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  80. Keller R.J., Eisenbarth G.S., Jackson R.A. Insulin prophylaxis in individuals at risk of type 1 diabetes. Lancet 341: 927, 1993.

    PubMed  CAS  Google Scholar 

  81. Dean B.M., McNally J.M., Bonifacio E., Jennings A.M., Dunger D.B., Gale E.A.M., Bottazzo G.F. Comparison of insulin autoantibodies in diabetes related and normal populations by precise displacement ELISA. Diabetes 38: 1275, 1989.

    PubMed  CAS  Google Scholar 

  82. Baekkeskov S., Aanstoot H.J., Fu Q., Jaffe M., Kim J., Quan J., Richter W., Shi Y. The glutamate decarboxylase and 38kD autoantigens in type 1 diabetes: aspects of structure and epitope recognition. Autoimmunity 15(suppl.): 24, 1993.

    PubMed  Google Scholar 

  83. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L. Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J. Exp. Med. 172: 789, 1990.

    PubMed  CAS  Google Scholar 

  84. Christie M.R., Hollands J.A., Brown T.J., Michelsen B.K., Delovitch T.L. Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest. 92: 240, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  85. Christie M.R., Genovese S., Cassidy D., Bosi E., Brown T.J., Bonifacio E., Bottazzo G.F. Autoantibodies to 37k islet cell antigen discriminate rapid progressors to insulin-dependent diabetes amongst glutamate decarboxylase antibody-positive individuals with endocrine autoimmunity. (Submitted)

  86. Christie M.R., Tun R., Lo S., Cassidy D., Brown T.J., Hollands J., Shattock M., Bottazzo G.F., Leslie R.D.G. Antibodies to glutamic acid decarboxylase and tryptic fragments of islet 64kD antigen as distinct markers for the development of insulin-dependent diabetes. Studies with identical twins. Diabetes 41: 782, 1992.

    CAS  Google Scholar 

  87. Christie M.R. Characterization of distinct islet protein autoantigens associated with type 1 diabetes. Autoimmunity 15: (suppl): 1, 1993.

    PubMed  Google Scholar 

  88. Roep B.O., Arden S.D., DeVries R.P., Hutton J.C. T-cell clones from a type I diabetes patient respond to insulin secretory granule proteins. Nature 345: 632, 1990.

    PubMed  CAS  Google Scholar 

  89. Roep B.O., Kallan A.A., Hazenbos W.L.W., Bruining G.J., Bailyes E.M., Arden S.D., Hutton J.C., De Vries R.R.P. T-cell reactivity to 38kD insulin secretory granule protein in patients with recent-onset type 1 diabetes Lancet 337: 1439, 1991.

  90. De Aizpurua H.J., Honeyman M.C., Harrison L.C. A 64kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun 5: 759, 1992.

    Google Scholar 

  91. Honeyman M.C., Cram D.S., Harrison L.C. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 42: 626, 1993.

    PubMed  CAS  Google Scholar 

  92. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S. Identification and cloning of a granule autoantigen (Carboxypeptidase-H) associated with type 1 diabetes. J. Clin. Endocrinol. Metab. 73: 1197, 1991.

    PubMed  CAS  Google Scholar 

  93. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.L.S., Martin S., Martin A., Powers A.C., Prochazka M., Naggert J., Leiter E.H., Eisenbarth G.S. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 92: 359, 1993.

    CAS  Google Scholar 

  94. Rabin D.U., Pleasic S.M., Palmer-Crocker R., Shapiro J.A. Cloning and expression of IDDM specific human autoantigens. Diabetes 41: 183, 1992.

    PubMed  CAS  Google Scholar 

  95. Karounos D.G., Thomas J.W. Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes 39: 1085, 1990.

    PubMed  CAS  Google Scholar 

  96. Bottazzo G.F., Dean B.M., McNally J.M., Mackay E.H., Swift P.G.F., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313: 353, 1985.

    PubMed  CAS  Google Scholar 

  97. Tingle A.J., Lim G., Wright V.J., Dimmick J.E., Hunt J.A. Transplacental passage of islet cell antibody in infants of diabetic mothers. Pediatr. Res. 13: 1323, 1979.

    PubMed  CAS  Google Scholar 

  98. Dobersen M.J., Scharff J.E., Ginsberg-Fellner F., Notkins A.L. Cytotoxic autoantibodies to beta-cells in the serum of patients with insulin dependent diabetes mellitus N. Engl. J. Med. 303: 1493, 1980.

    CAS  Google Scholar 

  99. Lernmark A., Sehlin J., Taljedal I.B., Kromann H., Nerup J. Possible toxic effects of normal and diabetic patient serum on pancreatic B-cells. Diabetologia 14: 25, 1978.

    PubMed  CAS  Google Scholar 

  100. Rittenhouse H.G., Oxender D.L., Pek S., Ar D. Complement mediated cytotoxic effects on pancreatic islets with sera from diabetic patients. Diabetes 29: 317, 1980.

    PubMed  CAS  Google Scholar 

  101. Eisenbarth G.S., Morris M.A., Scearce R.M. Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J. Clin. Invest. 67: 403, 1981.

    PubMed Central  PubMed  CAS  Google Scholar 

  102. Kanatsuna T., Freedman Z.R., Rubenstein A.H., Lernmark A. Effect of islet cell surface antibodies and complement on the release of insulin and chromium from perifused ß cells. Clin. Exp. Immunol. 47: 85, 1982.

    PubMed Central  PubMed  CAS  Google Scholar 

  103. Dobersen M.J., Scharff J.E. Preferential lysis of pancreatic ß-cells by islet cell surface antibodies. Diabetes 31: 459, 1982.

    PubMed  CAS  Google Scholar 

  104. Toguchi Y., Ginsberg-Fellner F., Rubinstein P. Cytotoxic islet cell surface antibodies (ICSA) in patients with type I diabetes and their first degree relatives. Diabetes 34: 855, 1985.

    PubMed  CAS  Google Scholar 

  105. Maruyama T., Takei I., Matsuba I., Tsuruoka A., Taniyama M., Ikeda Y., Kataoka K., Abe M., Matsuki S. Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells. Diabetologia 26: 30, 1984.

    PubMed  CAS  Google Scholar 

  106. Michaelis D., Rjasanowski I., Helmke B., Kohnert K.D., Hildman W., Keilacker H., Richter K.V. Lack od strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity and HLA antigens in newly diagnosed type I diabetics. Biomed. Biochim. Acta 44: 99, 1985.

    PubMed  CAS  Google Scholar 

  107. Kanatsuna T., Lernmark A., Rubenstein A.H., Steiner D. Block in insulin release from column-perfused pancreatic beta cells induced by islet cell surface antibodies and complement. Diabetes 30: 231, 1981.

    PubMed  CAS  Google Scholar 

  108. Sai P., Boitard C., Debray-Sachs M., Pouplard A., Assan R., Hamburger J. Complement-fixing islet cell antibodies from some diabetic patients alter insulin release in vitro. Diabetes 30: 1051, 1981.

    PubMed  CAS  Google Scholar 

  109. Kanatsuna T., Baekkeskov S., Lernmark A., Ludvigsson J. Immunoglobulin from insulin dependent diabetic children inhibits glucose-induced insulin release. Diabetes 32: 520, 1983.

    PubMed  CAS  Google Scholar 

  110. Sensi M., Zuccarini O., Spencer K.M., Beales P., Pujol-Borrell R., Pozzilli P. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type I diabetes. Diabetes Res 2: 1, 1985.

    PubMed  CAS  Google Scholar 

  111. Svenningsen A., Dyrberg T., Gerling I., Lernmark A., Mackay P., Rabinovitch A. Inhibition of insulin release after passive transfer of immunoglobulin from insulin dependent diabetic children to mice. J. Clin. Endocrinol. Metab. 57: 1301, 1983.

    PubMed  CAS  Google Scholar 

  112. Boitard C., Sai P., Debray-Sachs M., Assan R., Hamburger J. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed towards pancreatic islets. Clin. Exp. Immunol. 55: 571, 1984.

    CAS  Google Scholar 

  113. Johnson J.H., Crider B.P., McCorki K., Alford M., Linger R.H. Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 653, 1990.

    PubMed  CAS  Google Scholar 

  114. Juntti-Berggren L., Larsson O., Rorsman P., Ammala C., Bokvist K., Wahlander K., Nicotera P., Dypbukt J., Orrenius S., Hallberg A., Berggren P.O. Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes. Science 261: 86, 1993.

    PubMed  CAS  Google Scholar 

  115. Borch-Johnsen K., Joner G., Mandrup-Poulsen T., Christy M., Zachau-Christiansen B., Kastrup K., Nerup J. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. Lancet ii: 1083, 1984.

    Google Scholar 

  116. Karjalainen J., Martin J.M., Knip M., Honen S., Robinson B.H., Savilahti E., Akerblom H.K., Dosch H.M. Evidence for a bovine albumin peptide as a candidate trigger of Type 1 diabetes. N. Engl. J. Med. 327: 302, 1992.

    PubMed  CAS  Google Scholar 

  117. Dahlquist G., Savilathi E., Landin-Olsson M. An increased level of antibodies to ß-lactoglobulin is a risk determinant for early-onset Type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow’s milk. Diabetologia 35: 980, 1992.

    PubMed  CAS  Google Scholar 

  118. Atkinson M.A., Bowman M.A., Kao K.J., Campbell L., Dush P.J., Shah S.C., Sirnell O., Maclaren N.K. Lack of immune responsivness to bovine serum albumin in insulin dependent diabetes. N. Engl. J. Med. 329: 1853, 1993.

    PubMed  CAS  Google Scholar 

  119. Kaufman D.L., Erlander M.G., Clare-Salzer M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89: 283, 1992.

    PubMed Central  PubMed  CAS  Google Scholar 

  120. Tuvemo T., Dahlquist G., Frisk G., Blom L., Friman G., Landin-Olsson M., Diderholm H. The Swedish childhood diabetes study III: IgM against Coxackie B viruses in newly diagnosed Type 1 (insulin-dependent) diabetic children — no evidence of increased antibody frequency. Diabetologia 32: 745, 1989.

    PubMed  CAS  Google Scholar 

  121. King M.L., Shaikh A., Bidwell D., Voller A., Banatvala J.E. Coxsackie B virus-specific IgM responses in children with insulin-dependent diabetes mellitus. Lancet i: 1397, 1983.

    Google Scholar 

  122. Banatvala J.E., Bryant H., Scherntaner G., Borkenstein M., Schober E., Brown D., De Silva L.M., Menser M.A., Silink M. Coxackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria and Australia. Lancet i: 1409, 1985.

    Google Scholar 

  123. Atkinson M., Bowman M., Darrow B., Kaufman D., Maclaren N.K. Cellular immunity to an epitope common to glutamate decarboxylase (GAD) and Coxackie virus in insulin dependent diabetes. 13th International Immunology and Diabetes Workshop, Abstract book, 22, 1994.

  124. Jones D.B., Duff G. Is there no role for heat-shock protein in diabetes? Lancet 337: 115, 1991.

    PubMed  CAS  Google Scholar 

  125. Jones D.B., Hunter N.R., Duff G.W. Heat-shock protein 65 as a ß cell antigen of insulin-dependent diabetes. Lancet 336: 583, 1990.

    PubMed  CAS  Google Scholar 

  126. Kampe O., Velloso L., Andersson A., Karlsson A. No role for 65 kD heat-shock protein in diabetes. Lancet 337: 1250, 1990.

    Google Scholar 

  127. Atkinson M.A., Maclaren N.K., Scharp D.W. No role for 65 kD heat-shock protein in diabetes. Lancet 337: 1250, 1990.

    Google Scholar 

  128. Elias D., Markovits D., Reshef T., Van Der Zee R., Cohen I.R. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOLDL/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87: 1576, 1990.

    PubMed Central  PubMed  CAS  Google Scholar 

  129. Serreze D.V., Leiter E.H., Kuff E.L., Jardieu P., Ishizaka K. Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes 37: 351, 1988.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, San Raffaele Hospital Scientific Institute, University of Milan, Via Olgettina 60, 20132, Milan, Italy

    Emanuele Bosi M.D. & E. Bonifacio

Authors
  1. Emanuele Bosi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Bonifacio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bosi, E., Bonifacio, E. Autoantibodies in insulin-dependent diabetes mellitus. J Endocrinol Invest 17, 521–531 (1994). https://doi.org/10.1007/BF03347746

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347746

Keywords

Search

Navigation